Brown R S, Shalhoub V, Coulter S, Alex S, Joris I, De Vito W, Lian J, Stein G S
Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655, USA.
Endocrinology. 2000 Jan;141(1):340-5. doi: 10.1210/endo.141.1.7258.
The TSH receptor plays a pivotal role in thyroid gland function, growth, and differentiation, but little is known about its role or regulation in the fetus and neonate. To explore these questions, we systematically evaluated TSH receptor gene expression at the level of messenger RNA (mRNA) in thyroid glands obtained from rat fetuses and neonates, from 14 days gestation to day 5 of postnatal life. Results were compared with histological evidence of differentiation and to thyroid-specific gene expression. Northern blot and RT-PCR analysis revealed that TSH mRNA was first detected at low levels on fetal day 15, but it increased 3- to 15-fold on fetal days 17-18. Up-regulation of TSH receptor mRNA on fetal day 17-18 was accompanied by the first appearance of colloid formation and of follicular development on morphological examination. It was also paralleled by increased expression of the thyroid-specific genes thyroglobulin (Tg) and thyroid peroxidase. Unexpectedly, TSH mRNA abundance was 2- to 3-fold higher in pregnant dams than in nonpregnant adult females or adult males. In view of the 8-day lapse between the first appearance of the thyroid diverticulum and up-regulation of TSH receptor gene expression, we conclude that pituitary TSH, acting through its receptor, plays an important role in terminal thyroid maturation, but it is not involved earlier in gestation. Similarly, these data support previous evidence that the weak thyrotropic activity of human CG could not be of significance in early fetal thyroid gland development. The increased TSH receptor mRNA on fetal day 17-18 may be attributable to up-regulation by TSH, which is first secreted into the fetal circulation at this time. The significance of the increased TSH receptor expression during pregnancy remains to be explored.
促甲状腺激素(TSH)受体在甲状腺功能、生长和分化中起关键作用,但对其在胎儿和新生儿中的作用或调节知之甚少。为探讨这些问题,我们系统评估了从妊娠14天到出生后第5天的大鼠胎儿和新生儿甲状腺中促甲状腺激素受体基因在信使核糖核酸(mRNA)水平的表达。将结果与分化的组织学证据以及甲状腺特异性基因表达进行比较。Northern印迹和逆转录-聚合酶链反应(RT-PCR)分析显示,TSH mRNA在胎儿第15天首次被检测到,水平较低,但在胎儿第17 - 18天增加了3至15倍。胎儿第17 - 18天TSH受体mRNA的上调伴随着形态学检查中胶体形成和滤泡发育的首次出现。它还与甲状腺特异性基因甲状腺球蛋白(Tg)和甲状腺过氧化物酶表达的增加平行。出乎意料的是,妊娠母鼠中TSH mRNA丰度比未妊娠成年雌性或成年雄性高2至3倍。鉴于甲状腺憩室首次出现与TSH受体基因表达上调之间有8天的间隔,我们得出结论,垂体TSH通过其受体发挥作用,在甲状腺终末成熟中起重要作用,但在妊娠早期不涉及。同样,这些数据支持先前的证据,即人绒毛膜促性腺激素(hCG)微弱的促甲状腺活性在胎儿甲状腺早期发育中可能不重要。胎儿第17 - 18天TSH受体mRNA增加可能归因于TSH的上调,TSH此时首次分泌到胎儿循环中。妊娠期间TSH受体表达增加的意义仍有待探索。